BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sevastre A, Horescu C, Carina Baloi S, Cioc CE, Vatu BI, Tuta C, Artene SA, Danciulescu MM, Tudorache S, Dricu A. Benefits of Nanomedicine for Therapeutic Intervention in Malignant Diseases. Coatings 2019;9:628. [DOI: 10.3390/coatings9100628] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Vinnitskiy DZ, Luss AL, Krylov VB, Ustyuzhanina NE, Goryachaya AV, Nechaeva AM, Shtilman MI, Nifantiev NE, Mezhuev YO. Synthesis of Vectorized Nanoparticles Based on a Copolymer of N-Vinyl-2-Pyrrolidone with Allyl Glycidyl Ether and a Carbohydrate Vector. J Compos Sci 2022;6:247. [DOI: 10.3390/jcs6090247] [Reference Citation Analysis]
2 Nechaeva A, Artyukhov A, Luss A, Shtilman M, Gritskova I, Shulgin A, Motyakin M, Levina I, Krivoborodov E, Toropygin I, Chistyakov E, Gurevich L, Mezhuev Y. Synthesis of Amphiphilic Copolymers of N-Vinyl-2-pyrrolidone and Allyl Glycidyl Ether for Co-Delivery of Doxorubicin and Paclitaxel. Polymers 2022;14:1727. [DOI: 10.3390/polym14091727] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Koksharov YA, Gubin SP, Taranov IV, Khomutov GB, Gulyaev YV. Magnetic Nanoparticles in Medicine: Progress, Problems, and Advances. J Commun Technol Electron 2022;67:101-16. [DOI: 10.1134/s1064226922020073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Dee G, Gun’ko YK. Magnetic nanoparticles and nanoobjects used for medical applications. Magnetic Materials and Technologies for Medical Applications 2022. [DOI: 10.1016/b978-0-12-822532-5.00006-6] [Reference Citation Analysis]
5 Ortiz-casas B, Galdámez-martínez A, Gutiérrez-flores J, Baca Ibañez A, Kumar Panda P, Santana G, de la Vega HA, Suar M, Gutiérrez Rodelo C, Kaushik A, Kumar Mishra Y, Dutt A. Bio-acceptable 0D and 1D ZnO nanostructures for cancer diagnostics and treatment. Materials Today 2021;50:533-69. [DOI: 10.1016/j.mattod.2021.07.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 14.0] [Reference Citation Analysis]
6 Ordikhani F, Zandi N, Mazaheri M, Luther GA, Ghovvati M, Akbarzadeh A, Annabi N. Targeted nanomedicines for the treatment of bone disease and regeneration. Med Res Rev 2021;41:1221-54. [PMID: 33347711 DOI: 10.1002/med.21759] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Horescu C, Elena Cioc C, Tuta C, Sevastre AS, Tache DE, Alexandru O, Artene SA, Danoiu S, Dricu A, Stefana Oana P. The effect of temozolomide in combination with doxorubicin in glioblastoma cells in vitro. J Immunoassay Immunochem 2020;41:1033-43. [PMID: 33021886 DOI: 10.1080/15321819.2020.1819309] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Soetaert F, Korangath P, Serantes D, Fiering S, Ivkov R. Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies. Adv Drug Deliv Rev 2020;163-164:65-83. [PMID: 32603814 DOI: 10.1016/j.addr.2020.06.025] [Cited by in Crossref: 113] [Cited by in F6Publishing: 122] [Article Influence: 37.7] [Reference Citation Analysis]